beta-D-Galactose pentaacetate is a negative regulator of insulin with plasma membrane penetrating ability and can be hydrolyzed by intracellular esterases. beta-D-Galactose pentaacetate inhibits Leucine (HY-N0486)-induced insulin release in Wistar rat islets, potentially preventing excessive insulin release in pathological conditions[1][2][3].
Molecular Weight:
390.34
Purity:
99.86
CAS Number:
[4163-60-4]
Formula:
C16H22O11
Target:
Insulin Receptor
Application Notes:
MCE Product type: Biochemical Assay Reagents
* VAT and and shipping costs not included. Errors and price changes excepted
